Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Working Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   Working Capital/Sales(x) 2.211.573.273.576.67

What is the latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 2.21 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.21
Mar20241.57
Mar20233.27
Mar20223.57
Mar20176.67

How is Working Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2025 2.21
40.76
Mar2024 1.57
-51.99
Mar2023 3.27
-8.40
Mar2022 3.57
-46.48
Mar2017 6.67 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Working Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,412.8 Cr 4.9% 7.7% -19.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.9%

7.7%

-19.8%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses